AbbVie supports disclosure and transparency on interactions between the healthcare industry and healthcare professionals to ensure public trust and confidence.
AbbVie supports disclosure and transparency on interactions between the healthcare industry and healthcare professionals to ensure public trust and confidence.
In alignment with the member companies of Medicines New Zealand, AbbVie has undertaken to be open and transparent when we provide a reportable payment to a healthcare professional or a third party as directed by a healthcare professional. Reportable payments or transfers of value are:
AbbVie has prepared the report for publication in accordance with the Medicines New Zealand Guidelines for Disclosure of Transfers of Value from Pharmaceutical Companies to Healthcare Professionals and New Zealand’s Privacy legislation. The report identifies healthcare professionals by name where their consent has been provided.
The report is provided as a downloadable Excel file.
To comply with our privacy obligations, the report may be amended from time to time. The report here contains the most up to date information. Any use or disclosure of the data by a third party is the responsibility of that third party, who must comply with the New Zealand Privacy Act 2020.
For further information about the details in the report, please click here.
This report will be available for at least three years from the date of publication.
AbbVie collaborates and co-creates with the groups working with and representing patients. The grants we provide patient groups to support their ongoing work can be found here.
AbbVie supports the enhancement of medical knowledge and the quality use of medicines through sponsoring independently organised educational events. These events are primarily offered by societies, colleges, universities or other recognised healthcare professional organisations.
AbbVie’s sponsorships paid to organisations in support of independently organised educational events can be found here.
The product-specific Internet site that you have requested is intended for the residents of a particular country or countries, as noted on that site. As a result, the site may contain information on pharmaceuticals that are not approved in other countries or region. If you are a resident of a country other than those to which the site is directed, please return to AbbVie.com or contact your local AbbVie affiliate to obtain the appropriate product information for your country of residence. The Internet site that you have requested may not be optimized to your screen size. Do you wish to continue to this product-specific site?